PDF herunterladen
Semin Liver Dis 2015; 35(01): 075-080
DOI: 10.1055/s-0034-1397351
Thieme Medical Publishers 333 Seventh Avenue, New York, NY 10001, USA.

Interaction of Host Cell microRNAs with the HCV RNA Genome during Infection of Liver Cells

Cecilia D. Sedano
1   Department of Microbiology and Immunology, Stanford University School of Medicine, Stanford, California
,
Peter Sarnow
1   Department of Microbiology and Immunology, Stanford University School of Medicine, Stanford, California
› Institutsangaben
Weitere Informationen

Publikationsverlauf

Publikationsdatum:
29. Januar 2015 (online)

    Lizenzen und Reprints

Abstract

It has remained an enigma how hepatitis C viral (HCV) RNA can persist in the liver of infected patients for many decades. With the recent discovery of roles for microRNAs in gene expression, it was reported that the HCV RNA genome subverts liver-specific microRNA miR-122 to protect its 5′ end from degradation by host cell exoribonucleases. Sequestration of miR-122 in cultured liver cells and in the liver of chimpanzees by small, modified antisense RNAs resulted in dramatic loss of HCV RNA and viral yield. This finding led to the first successful human trial in which subcutaneous administration of antisense molecules against miR-122 lowered viral yield in HCV patients, without the emergence of resistant virus. In this review, the authors summarize the molecular mechanism by which miR-122 protects the HCV RNA genome from degradation by exoribonucleases Xrn1 and Xrn2 and discuss the application of miR-122 antisense molecules in the clinic.

Keywords

hepatitis C virus - microRNA - exoribonucleases
 

  • References

  • 1 Hoofnagle JH. Course and outcome of hepatitis C. Hepatology 2002; 36 (5) (Suppl. 01) S21-S29
    CrossrefPubMedGoogle Scholar
  • 2 Lavanchy D. Evolving epidemiology of hepatitis C virus. Clin Microbiol Infect 2011; 17 (2) 107-115
    CrossrefPubMedGoogle Scholar
  • 3 Casey LC, Lee WM. Hepatitis C virus therapy update 2013. Curr Opin Gastroenterol 2013; 29 (3) 243-249
    PubMedGoogle Scholar
  • 4 Bartenschlager R, Penin F, Lohmann V, André P. Assembly of infectious hepatitis C virus particles. Trends Microbiol 2011; 19 (2) 95-103
    CrossrefPubMedGoogle Scholar
  • 5 Cannell IG, Kong YW, Bushell M. How do microRNAs regulate gene expression?. Biochem Soc Trans 2008; 36 (Pt 6) 1224-1231
    CrossrefPubMedGoogle Scholar
  • 6 Lewis BP, Shih IH, Jones-Rhoades MW, Bartel DP, Burge CB. Prediction of mammalian microRNA targets. Cell 2003; 115 (7) 787-798
    CrossrefPubMedGoogle Scholar
  • 7 Esquela-Kerscher A, Slack FJ. Oncomirs - microRNAs with a role in cancer. Nat Rev Cancer 2006; 6 (4) 259-269
    CrossrefPubMedGoogle Scholar
  • 8 Lagos-Quintana M, Rauhut R, Lendeckel W, Tuschl T. Identification of novel genes coding for small expressed RNAs. Science 2001; 294 (5543) 853-858
    CrossrefPubMedGoogle Scholar
  • 9 Lee Y, Jeon K, Lee JT, Kim S, Kim VN. MicroRNA maturation: stepwise processing and subcellular localization. EMBO J 2002; 21 (17) 4663-4670
    CrossrefPubMedGoogle Scholar
  • 10 Sontheimer EJ, Carthew RW. Silence from within: endogenous siRNAs and miRNAs. Cell 2005; 122 (1) 9-12
    CrossrefPubMedGoogle Scholar
  • 11 Chen Y, Boland A, Kuzuoğlu-Öztürk D , et al. A DDX6-CNOT1 complex and W-binding pockets in CNOT9 reveal direct links between miRNA target recognition and silencing. Mol Cell 2014; 54 (5) 737-750
    CrossrefPubMedGoogle Scholar
  • 12 Meijer HA, Kong YW, Lu WT , et al. Translational repression and eIF4A2 activity are critical for microRNA-mediated gene regulation. Science 2013; 340 (6128) 82-85
    CrossrefPubMedGoogle Scholar
  • 13 Djuranovic S, Nahvi A, Green R. miRNA-mediated gene silencing by translational repression followed by mRNA deadenylation and decay. Science 2012; 336 (6078) 237-240
    CrossrefPubMedGoogle Scholar
  • 14 Cullen BR. Viruses and microRNAs: RISCy interactions with serious consequences. Genes Dev 2011; 25 (18) 1881-1894
    CrossrefPubMedGoogle Scholar
  • 15 Gerlach D, Kriventseva EV, Rahman N, Vejnar CE, Zdobnov EM. miROrtho: computational survey of microRNA genes. Nucleic Acids Res 2009; 37 (Database issue): D111-D117
    CrossrefPubMedGoogle Scholar
  • 16 Chang J, Nicolas E, Marks D , et al. miR-122, a mammalian liver-specific microRNA, is processed from hcr mRNA and may downregulate the high affinity cationic amino acid transporter CAT-1. RNA Biol 2004; 1 (2) 106-113
    CrossrefPubMedGoogle Scholar
  • 17 Esau C, Davis S, Murray SF , et al. miR-122 regulation of lipid metabolism revealed by in vivo antisense targeting. Cell Metab 2006; 3 (2) 87-98
    CrossrefPubMedGoogle Scholar
  • 18 Janssen HL, Reesink HW, Lawitz EJ , et al. Treatment of HCV infection by targeting microRNA. N Engl J Med 2013; 368 (18) 1685-1694
    CrossrefPubMedGoogle Scholar
  • 19 Krützfeldt J, Rajewsky N, Braich R , et al. Silencing of microRNAs in vivo with 'antagomirs'. Nature 2005; 438 (7068) 685-689
    CrossrefPubMedGoogle Scholar
  • 20 Jopling CL, Yi M, Lancaster AM, Lemon SM, Sarnow P. Modulation of hepatitis C virus RNA abundance by a liver-specific microRNA. Science 2005; 309 (5740) 1577-1581
    CrossrefPubMedGoogle Scholar
  • 21 Machlin ES, Sarnow P, Sagan SM. Masking the 5′ terminal nucleotides of the hepatitis C virus genome by an unconventional microRNA-target RNA complex. Proc Natl Acad Sci U S A 2011; 108 (8) 3193-3198
    CrossrefPubMedGoogle Scholar
  • 22 Li Y, Masaki T, Yamane D, McGivern DR, Lemon SM. Competing and noncompeting activities of miR-122 and the 5′ exonuclease Xrn1 in regulation of hepatitis C virus replication. Proc Natl Acad Sci U S A 2013; 110 (5) 1881-1886
    CrossrefPubMedGoogle Scholar
  • 23 Sedano CD, Sarnow P. Subversion of liver-specific miR-122 by hepatitis C virus RNA genome to protect against exoribonuclease Xrn2. Cell Host Microbe 2014; 16 (2) 257-264
    CrossrefPubMedGoogle Scholar
  • 24 Amberg DC, Goldstein AL, Cole CN. Isolation and characterization of RAT1: an essential gene of Saccharomyces cerevisiae required for the efficient nucleocytoplasmic trafficking of mRNA. Genes Dev 1992; 6 (7) 1173-1189
    CrossrefPubMedGoogle Scholar
  • 25 Larimer FW, Stevens A. Disruption of the gene XRN1, coding for a 5′----3′ exoribonuclease, restricts yeast cell growth. Gene 1990; 95 (1) 85-90
    CrossrefPubMedGoogle Scholar
  • 26 Stevens A. An exoribonuclease from Saccharomyces cerevisiae: effect of modifications of 5′ end groups on the hydrolysis of substrates to 5′ mononucleotides. Biochem Biophys Res Commun 1978; 81 (2) 656-661
    CrossrefPubMedGoogle Scholar
  • 27 Stevens A. Purification and characterization of a Saccharomyces cerevisiae exoribonuclease which yields 5′-mononucleotides by a 5′ leads to 3′ mode of hydrolysis. J Biol Chem 1980; 255 (7) 3080-3085
    PubMedGoogle Scholar
  • 28 Chang JH, Xiang S, Xiang K, Manley JL, Tong L. Structural and biochemical studies of the 5′→3′ exoribonuclease Xrn1. Nat Struct Mol Biol 2011; 18 (3) 270-276
    CrossrefPubMedGoogle Scholar
  • 29 Heyer WD, Johnson AW, Reinhart U, Kolodner RD. Regulation and intracellular localization of Saccharomyces cerevisiae strand exchange protein 1 (Sep1/Xrn1/Kem1), a multifunctional exonuclease. Mol Cell Biol 1995; 15 (5) 2728-2736
    CrossrefPubMedGoogle Scholar
  • 30 Johnson AW. Rat1p and Xrn1p are functionally interchangeable exoribonucleases that are restricted to and required in the nucleus and cytoplasm, respectively. Mol Cell Biol 1997; 17 (10) 6122-6130
    CrossrefPubMedGoogle Scholar
  • 31 Käslin E, Heyer WD. A multifunctional exonuclease from vegetative Schizosaccharomyces pombe cells exhibiting in vitro strand exchange activity. J Biol Chem 1994; 269 (19) 14094-14102
    PubMedGoogle Scholar
  • 32 Bashkirov VI, Scherthan H, Solinger JA, Buerstedde JM, Heyer WD. A mouse cytoplasmic exoribonuclease (mXRN1p) with preference for G4 tetraplex substrates. J Cell Biol 1997; 136 (4) 761-773
    CrossrefPubMedGoogle Scholar
  • 33 Till DD, Linz B, Seago JE , et al. Identification and developmental expression of a 5′-3′ exoribonuclease from Drosophila melanogaster. Mech Dev 1998; 79 (1–2) 51-55
    CrossrefPubMedGoogle Scholar
  • 34 Kastenmayer JP, Green PJ. Novel features of the XRN-family in Arabidopsis: evidence that AtXRN4, one of several orthologs of nuclear Xrn2p/Rat1p, functions in the cytoplasm. Proc Natl Acad Sci U S A 2000; 97 (25) 13985-13990
    CrossrefPubMedGoogle Scholar
  • 35 Li CH, Irmer H, Gudjonsdottir-Planck D , et al. Roles of a Trypanosoma brucei 5′->3′ exoribonuclease homolog in mRNA degradation. RNA 2006; 12 (12) 2171-2186
    CrossrefPubMedGoogle Scholar
  • 36 Chatterjee S, Grosshans H. Active turnover modulates mature microRNA activity in Caenorhabditis elegans . Nature 2009; 461 (7263) 546-549
    CrossrefPubMedGoogle Scholar
  • 37 Petfalski E, Dandekar T, Henry Y, Tollervey D. Processing of the precursors to small nucleolar RNAs and rRNAs requires common components. Mol Cell Biol 1998; 18 (3) 1181-1189
    CrossrefPubMedGoogle Scholar
  • 38 Brannan K, Kim H, Erickson B , et al. mRNA decapping factors and the exonuclease Xrn2 function in widespread premature termination of RNA polymerase II transcription. Mol Cell 2012; 46 (3) 311-324
    CrossrefPubMedGoogle Scholar
  • 39 Kim M, Krogan NJ, Vasiljeva L , et al. The yeast Rat1 exonuclease promotes transcription termination by RNA polymerase II. Nature 2004; 432 (7016) 517-522
    CrossrefPubMedGoogle Scholar
  • 40 Pearson EL, Moore CL. Dismantling promoter-driven RNA polymerase II transcription complexes in vitro by the termination factor Rat1. J Biol Chem 2013; 288 (27) 19750-19759
    CrossrefPubMedGoogle Scholar
  • 41 West S, Gromak N, Proudfoot NJ. Human 5′ —> 3′ exonuclease Xrn2 promotes transcription termination at co-transcriptional cleavage sites. Nature 2004; 432 (7016) 522-525
    CrossrefPubMedGoogle Scholar
  • 42 Jones DM, Domingues P, Targett-Adams P, McLauchlan J. Comparison of U2OS and Huh-7 cells for identifying host factors that affect hepatitis C virus RNA replication. J Gen Virol 2010; 91 (Pt 9) 2238-2248
    CrossrefPubMedGoogle Scholar
  • 43 Ariumi Y, Kuroki M, Kushima Y , et al. Hepatitis C virus hijacks P-body and stress granule components around lipid droplets. J Virol 2011; 85 (14) 6882-6892
    CrossrefPubMedGoogle Scholar
  • 44 Pager CT, Schütz S, Abraham TM, Luo G, Sarnow P. Modulation of hepatitis C virus RNA abundance and virus release by dispersion of processing bodies and enrichment of stress granules. Virology 2013; 435 (2) 472-484
    CrossrefPubMedGoogle Scholar
  • 45 Scheller N, Mina LB, Galão RP , et al. Translation and replication of hepatitis C virus genomic RNA depends on ancient cellular proteins that control mRNA fates. Proc Natl Acad Sci U S A 2009; 106 (32) 13517-13522
    CrossrefPubMedGoogle Scholar
  • 46 Wilson JA, Zhang C, Huys A, Richardson CD. Human Ago2 is required for efficient microRNA 122 regulation of hepatitis C virus RNA accumulation and translation. J Virol 2011; 85 (5) 2342-2350
    CrossrefPubMedGoogle Scholar
  • 47 Roberts AP, Lewis AP, Jopling CL. miR-122 activates hepatitis C virus translation by a specialized mechanism requiring particular RNA components. Nucleic Acids Res 2011; 39 (17) 7716-7729
    CrossrefPubMedGoogle Scholar
  • 48 Shimakami T, Yamane D, Jangra RK , et al. Stabilization of hepatitis C virus RNA by an Ago2-miR-122 complex. Proc Natl Acad Sci U S A 2012; 109 (3) 941-946
    CrossrefPubMedGoogle Scholar
  • 49 Zhang C, Huys A, Thibault PA, Wilson JA. Requirements for human Dicer and TRBP in microRNA-122 regulation of HCV translation and RNA abundance. Virology 2012; 433 (2) 479-488
    CrossrefPubMedGoogle Scholar
  • 50 Cox EM, Sagan SM, Mortimer SA, Doudna JA, Sarnow P. Enhancement of hepatitis C viral RNA abundance by precursor miR-122 molecules. RNA 2013; 19 (12) 1825-1832
    CrossrefPubMedGoogle Scholar
  • 51 Pedersen IM, Cheng G, Wieland S , et al. Interferon modulation of cellular microRNAs as an antiviral mechanism. Nature 2007; 449 (7164) 919-922
    CrossrefPubMedGoogle Scholar
  • 52 Murakami Y, Aly HH, Tajima A, Inoue I, Shimotohno K. Regulation of the hepatitis C virus genome replication by miR-199a. J Hepatol 2009; 50 (3) 453-460
    PubMedGoogle Scholar
  • 53 Friebe P, Lohmann V, Krieger N, Bartenschlager R. Sequences in the 5′ nontranslated region of hepatitis C virus required for RNA replication. J Virol 2001; 75 (24) 12047-12057
    CrossrefPubMedGoogle Scholar
  • 54 Esquela-Kerscher A, Trang P, Wiggins JF , et al. The let-7 microRNA reduces tumor growth in mouse models of lung cancer. Cell Cycle 2008; 7 (6) 759-764
    CrossrefPubMedGoogle Scholar
  • 55 Schubert M, Spahn M, Kneitz S , et al. Distinct microRNA expression profile in prostate cancer patients with early clinical failure and the impact of let-7 as prognostic marker in high-risk prostate cancer. PLoS ONE 2013; 8 (6) e65064
    CrossrefPubMedGoogle Scholar
  • 56 Teng GG, Wang WH, Dai Y, Wang SJ, Chu YX, Li J. Let-7b is involved in the inflammation and immune responses associated with Helicobacter pylori infection by targeting Toll-like receptor 4. PLoS ONE 2013; 8 (2) e56709
    CrossrefPubMedGoogle Scholar
  • 57 Cheng JC, Yeh YJ, Tseng CP , et al. Let-7b is a novel regulator of hepatitis C virus replication. Cell Mol Life Sci 2012; 69 (15) 2621-2633
    CrossrefPubMedGoogle Scholar
  • 58 Elmén J, Lindow M, Schütz S , et al. LNA-mediated microRNA silencing in non-human primates. Nature 2008; 452 (7189) 896-899
    CrossrefPubMedGoogle Scholar
  • 59 Hsu SH, Wang B, Kota J , et al. Essential metabolic, anti-inflammatory, and anti-tumorigenic functions of miR-122 in liver. J Clin Invest 2012; 122 (8) 2871-2883
    CrossrefPubMedGoogle Scholar
  • 60 Tsai WC, Hsu SD, Hsu CS , et al. MicroRNA-122 plays a critical role in liver homeostasis and hepatocarcinogenesis. J Clin Invest 2012; 122 (8) 2884-2897
    CrossrefPubMedGoogle Scholar
  • 61 Henke JI, Goergen D, Zheng J , et al. MicroRNA-122 stimulates translation of hepatitis C virus RNA. EMBO J 2008; 27 (24) 3300-3310
    CrossrefPubMedGoogle Scholar